Veterinary CROs Market is expected to reach US$ 1,440.15 Mn in 2027

by Sameer Joshi or 31-Jan-2020
     Request For Sample

Report : Veterinary CROs Market to 2027 - Global Analysis and Forecasts By Service Type (Clinical Trials, Toxicology, Market Authorization and Regulatory Support, Others); Application (Pet, Livestock, Wild); Indication (Oncology, Infectious Diseases, Neurology, Others); End-User (Animal Husbandry, Others) and Geography

Pet segment is expected to drive the growth of the global Veterinary CROSs Market by Component

According to a new market research study of ‘Veterinary CROSs Market to 2027 – Global Analysis and Forecasts by Service Type, Application and Indication and End-User.’ The global Veterinary CROSs market is anticipated to reach US$ 1,440.15 Mn in 2027 from US$ 710.81 Mn in 2019. The market is anticipated to grow with a CAGR of 9.3% from 2020-2027. The report provides trends prevailing in the global veterinary CROSs market and the factors driving market along with those that act as hindrances.

In order to rise in prevalence of veterinary disease The animals are playing important aspect in terms of clinical trials. Veterinary contract research organizations services protect and improve the health, efficiency and marketability of the livestock, animal products and veterinary biologics of our nation by preventing, regulating or removing animal diseases, and by tracking and promoting animal health and productivity. For instance, in between January - April 2015, disease reports in North and West Africa, Middle East and African region, primarily included an upsurges of Foot and Mouth Disease (FMD) and H5N1 highly pathogenic avian influenza (HPAI) raising a  global economic concerns. Disease like Lumpy Skin Disease (LSD), Foot-and-Mouth Disease, Hemorrhagic Septicemia, Black Quarter, Zoonotic disease events are leading to death of the animals, for the wellbeing of animals the veterinary CROSs are taking steps for the clinical trial steps for the veterinary medicines. Thus, the increasing in incidence of veterinary diseases leading to drive the growth of veterinary CROS market.

The global veterinary CROSs market, based on application, was segmented as pet, livestock, and wild. Pet led the market in 2019, contributing to have the highest market share and is expected to retain its dominance during the forecast period from 2020 to 2027.

Leading companies operating in the veterinary CROSs market are Charles River Laboratories, Inc., Clinvet, Klifovet Ag, Löhlein and Wolf Vet Research, Oncovet Clinical Research, Ondax Scientific, Triveritas, Veterinary Research Management (VRM) LTD, VetPharm, Inc., Vetspin SRL among others.

The report segments Global Veterinary CROS Market as follows:

Global Veterinary CROS Market - By Service Type

  • Clinical Trials
  • Toxicology
  • Market Authorization and Regulatory Support
  • Others

Global Veterinary CROSs Market - By Application

  • Pet
  • Livestock
  • Wild

Global Veterinary CROSs Market - By Indication

  • Oncology
  • Infectious Diseases
  • Neurology
  • Others

Global Veterinary CROSs Market - By End-User

  • Biopharmaceutical Companies
  • Others

Global Veterinary CROSs Market - By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • U.K
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • U.A.E
    • South Africa
  • South & Central America (SCAM)
    • Brazil
    • Argentina 

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@reportsweb.com